<DOC>
	<DOCNO>NCT00671814</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics single rise oral dos multiple oral dos TR-701</brief_summary>
	<brief_title>Single Multiple Ascending Dose Pharmacokinetic Study TR701 Healthy Adults</brief_title>
	<detailed_description>This evaluation TR-701 double-blind , placebo-controlled , randomize , single ( Part A ) multiple ( Part B ) ascend dose safety , tolerance , PK administer capsule normal , healthy adult volunteer . The study sequential Part A Part B ( i.e. , stagger leap frog ) , slight overlap last cohort Part A first cohort Part B .</detailed_description>
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Torezolid phosphate</mesh_term>
	<criteria>good health body mass index 20 29.9 kg/m2 female subject must either postmenopausal least 1 year , surgically sterile , abstinent , agree use effective method birth control history clinical manifestation clinically significant disorder history hypersensitivity allergy drug compound history stomach intestinal surgery resection history alcoholism drug addiction within 1 year use tobaccocontaining nicotinecontaining product within 6 month use medication use alcoholcontaining , grapefruitcontaining , caffeinecontaining food beverage ; food beverage high level tyramine pregnancy , lactation , breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>antibiotic</keyword>
</DOC>